Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2026

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology

Understand how pharmaceutical and biotechnology companies structure, negotiate and implement co-promotion and co-marketing partnerships.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides comprehensive intelligence on co-commercialization dealmaking across the life sciences sector.

The report brings together 523 announced co-promotion and co-marketing deals, providing detailed analysis of how companies are using shared commercialization partnerships to access markets, combine commercial capabilities and maximize the value of pharmaceutical and biotechnology assets.

Rather than simply identifying transactions, the report enables users to examine who is partnering, how deals are structured, which assets and therapeutic areas are attracting activity, and what can be learned from publicly available deal terms and contract documents.

It is designed as a practical intelligence and benchmarking resource for business development, licensing, commercial strategy, alliance management and legal teams involved in evaluating or negotiating co-commercialization opportunities.

Understand the co-promotion and co-marketing deal landscape

The report analyzes deal activity from 2016 to 2026, including:

• Trends in co-promotion and co-marketing dealmaking by year
• Stage of development at the time of partnering
• Industry sector
• Therapy area
• Technology type
• Most active dealmakers
• Leading deals by disclosed value
• Strategic reasons for entering co-promotion and co-marketing agreements
• How co-commercialization dealmaking is evolving
• This enables users to identify where activity is concentrated, which companies are actively using these structures and how partnering strategies differ across the industry.
• Benchmark deal structures and commercial terms
• Co-promotion and co-marketing agreements can vary significantly in the allocation of commercial responsibilities, territories, rights and economics.

The report provides intelligence to help users understand and benchmark areas including:

• Promotion and commercialization responsibilities
• Geographic and market rights
• Exclusivity arrangements
• Revenue and profit-sharing mechanisms
• Manufacturing and supply responsibilities
• Term and termination provisions
• Sublicensing and subcontracting rights
• Governance and operational responsibilities
• Financial terms where disclosed
• For companies preparing for a transaction, this provides valuable reference points for determining how comparable partnerships have been structured.
• Learn from real-world contracts
• A major component of the report is access to publicly available contract documents where available.
• These agreements provide insight beyond the information normally disclosed in company announcements, allowing users to examine the detailed provisions governing selected co-promotion and co-marketing partnerships.
• Contract intelligence can help users understand how companies have addressed issues such as rights granted, revenue sharing, commercialization obligations, exclusivity, manufacturing, termination, confidentiality, dispute resolution and other negotiated provisions.
• Identify leading dealmakers and transactions
• The report identifies the Top 25 most active co-promotion and co-marketing dealmakers and examines leading transactions by disclosed deal value.
• This provides a clear view of the companies most actively pursuing shared commercialization strategies and enables users to investigate their deal activity in greater depth.
• Comprehensive deal directory
• The report includes a comprehensive directory of co-promotion and co-marketing deals announced from 2016 to 2026.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Each transaction is linked to its underlying deal record, providing a route to further deal information and, where available, associated contract documentation.
• Who should use this report?

The report is particularly relevant to:

• Business Development and Licensing teams
• Benchmark comparable transactions, identify active partners and support deal preparation and negotiation.
• Commercial Strategy teams
• Understand how companies share commercialization rights, capabilities, territories and responsibilities.
• Alliance Management teams
• Examine how existing co-commercialization partnerships have been structured and governed.
• Legal and Contracts teams
• Review real agreement language and compare contractual approaches across transactions.
• Corporate Strategy and Senior Management
• Assess co-promotion and co-marketing activity, leading participants and evolving partnering strategies.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing takes the underlying deal intelligence and applies it to the customer's own business, assets, technologies, target markets or partnering objectives.
• Depending on requirements, this can include identification of relevant comparable deals, prospective partners, deal structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's partnering situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.